Holista CollTech joins forces with GICC to develop works first nasal sanitiser, page-444

MC = $38.5 Million.
SOI = 275 Million.
Share Price = 0.14c
Cash = $4.3 Million.

"HCT announced that it has appointed Health Therapies LLC as its Exclusive Distributor for the United States for the NatShieldTM sanitiser amidst a sharp increase of Covid-19 coronavirus infection in the country. Health Therapies LLC has exclusivity for the U.S. market for 3 years and has committed to a minimum order of at least A$3.0 million per year. The orders are for NatShieldTM handheld sanitisers containing Path-Away®, a plant-based active ingredient. Path-Away® is proven effective for a broad spectrum of pathogens. Holista has a global collaboration with GICC LLL and sells NatShieldTM as a sanitiser which contains 3% Path-Away®."

"Shipment of the first 5,000 30-ml bottles will commence from Malaysia this week. Holista plans to bottle NatShieldTM within the United States by next month. Health Therapies LLC, headquartered in New Jersey, has a marketing team with 40 years of experience across multiple sales channels – online, retail and at airports.Dr Rajen Manicka, CEO of Holista CollTech, said, “The appointment of a U.S. distributor is timely because of the escalating infection rate in the country. We are shipping sanitisers out of Malaysia initially to meet the urgent needs."

"Holista plans to bottle NatShieldTM within the United States by next month. Discussions have begun with U.S. bottlers who, part of the logistic supply chain of GICC LLC, can commit to up to 1,000,000 bottles per month with capacity to scale further."

"Holista has commenced testing of NatShieldTM and PathAway® for its efficacy against Covid-19 at a recognised U.K. laboratory. Working with Holista, we have facilitated tests on Path-Away® to prove its efficacy against COVID-19. The tests are being conducted at a leading microbiology lab in the U.K. and results are expected by the middle of April 2020."

"Negotiations are underway on a number of further significant distribution and supply arrangements which when concluded will have the immediate effect of introducing NatShieldTM to new areas of the globe."

"Due to concerns about the continuing spread of the Covid-19 coronavirus, the Company has received expressions of interest from potential distributors or other buyers in:- United States- Canada, Europe - United Kingdom - Australia- India- Hong Kong- Middle East."

"The company is also developing online capabilities to better deliver NatShieldTM as needed."

"Due to the increased demand for the sanitisers, Holista has added bottling capacity in recent weeks. From an original two bottlers in Malaysia the Company has added bottling arrangements with two more Malaysian bottlers and three more in The Philippines, bringing the total to seven. All the bottlers – existing and newly appointed – have the required certifications to bottle NatShieldTM."

With these new bottling arrangements:
i) The Company can now produce NatShieldTM sanitisers in the following sizes: 20-ml, 30-ml and 60-ml.
ii) The total new bottling capacity has increased to 50,000 per week or about 200,000 per month.
iii) For the orders received up to 29 February 2020, the Company expects to complete shipments by the end of March 2020.

Expected news flow:-

1/ Sales update on orders for hand sanitisers.
2/ File a global patent on the nasal sanitising balm.
3/ Agreement with USA Bottlers to supply up 1 million bottles hand sanitiser per month for lucrative US markets.
4/ Lab test results for Natshield and Pathaway products effectiveness against Covid19 coronavirus and SARS etc.(due mid April)
5/ Negotiations underway further distribution and supply agreements in new Countries ( Canada, Europe, India + Middle East?).
6/ Launch online selling for hand sanitiser product.
7/ Launch of Nasal Sanitising Balm to commence production by the third quarter of 2020, ahead of distribution to global markets and the onset of the UK and European winter.

Company looks seriously undervalued compared to ZNO with potential to rapidly ramp up production in the very lucrative US market to 1 million bottles of hand sanitiser per month or more, and the launch of the very lucrative nasal balm sanitiser in coming months....